Publications by authors named "Michael Berlin"

Claim this Profile
C
Correction to "PROTACs Targeting BRM (SMARCA2) Afford Selective Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models".
Michael Berlin, Jennifer Cantley, Mark Bookbinder, Elizabeth Bortolon, Fabio Broccatelli

J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRPC5 controls the adrenaline-mediated counter regulation of hypoglycemia.
Jenny Bröker-Lai, José Rego Terol, Christin Richter, Ilka Mathar, Angela Wirth, Michael Berlin

EMBO J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OCaR1 endows exocytic vesicles with autoregulatory competence by preventing uncontrolled Ca2+ release, exocytosis, and pancreatic tissue damage.
Volodymyr Tsvilovskyy, Roger Ottenheijm, Ulrich Kriebs, Aline Schütz, Kalliope Nina Diakopoulos, Michael Berlin

J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PROTACs Targeting BRM (SMARCA2) Afford Selective Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models.
Michael Berlin, Jennifer Cantley, Mark Bookbinder, Elizabeth Bortolon, Fabio Broccatelli

J Med Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Liposome Systems for Enhancing the PK Properties of Bivalent PROTACs.
Ponien Kou, Elizabeth S Levy, An D Nguyen, Donglu Zhang, Shu Chen, Michael Berlin

Pharmaceutics· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers.
Jennifer Cantley, Xiaofen Ye, Emma Rousseau, Tom Januario, Brian D Hamman, Michael Berlin

Nat Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eight-year follow-up of excimer laser trabeculostomy alone and combined with phacoemulsification in patients with open-angle glaucoma.
Michael S Berlin, Jonathan Shakibkhou, Nirosha Tilakaratna, Ulrich Giers, Sylvia Linner Groth

J Cataract Refract Surg· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Excimer Laser Trabeculostomy within the Landscape of Minimally-Invasive Glaucoma Surgery.
Anne Nguyen, Brian Simon, Rebecca Doan, Emily Chen, Ryan Lamrani, Michael S Berlin

J Clin Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiomyocyte-Specific Deletion of Orai1 Reveals Its Protective Role in Angiotensin-II-Induced Pathological Cardiac Remodeling.
Sebastian Segin, Michael Berlin, Christin Richter, Rebekka Medert Veit Flockerzi, Paul Worley

Cells· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of new treatment modalities on adherence in glaucoma.
Frances Meier-Gibbons, Michael S Berlin, Marc Töteberg-Harms

Curr Opin Ophthalmol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty-four hour intraocular pressure measurements and home tonometry.
Frances Meier-Gibbons, Michael S Berlin, Marc Töteberg-Harms

Curr Opin Ophthalmol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study.
Eydie Miller Ellis, Michael S Berlin, Caroline L Ward, John A Sharpe, Alam Jamil

Br J Ophthalmol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing healthcare costs: can we influence the costs of glaucoma care?
Marc Töteberg-Harms, Michael S Berlin, Frances Meier-Gibbons

Curr Opin Ophthalmol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EP3/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study.
Michael S Berlin, Cheryl Rowe-Rendleman, Ike Ahmed, Douglas T Ross, Akifumi Fujii

Br J Ophthalmol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.
Manuel de Lera Ruiz, Junying Zheng, Michael Y Berlin, Kevin D McCormick, Robert G Aslanian

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
Qingbei Zeng, Stuart B Rosenblum, Zhaoxia Yang, Yueheng Jiang, Kevin D McCormick, Michael Berlin

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroidal C-21 heteroaryl thioethers. Part 3: pregn-4-eno-[3,2-c]pyrazole fused A ring modified steroids as selective glucocorticoid receptor modulators (dissociated steroids).
Purakkattle Biju, Hongwu Wang, John Anthes, Kevin McCormick, Robert Aslanian, Michael Berlin

Bioorg Med Chem Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroidal C-21 heteroaryl thioethers (Part 2): discovery of orally bioavailable selective glucocorticoid receptor modulators (dissociated steroids).
Purakkattle Biju, Kevin McCormick, Robert Aslanian, Michael Berlin, Daniel Solomon

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steroidal C-21 mercapto derivatives as dissociated steroids: discovery of an inhaled dissociated steroid.
Purakkattle Biju, Kevin McCormick, Robert Aslanian, Michael Berlin, Daniel Solomon

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histamine H3 receptor as a drug discovery target.
Michael Berlin, Christopher W Boyce, Manuel de Lera Ruiz

J Med Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the development of novel glucocorticoid receptor modulators.
Michael Berlin

Expert Opin Ther Pat· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of hERG inhibitory activity in the 4-piperidinyl urea series of H3 antagonists.
Michael Berlin, Yoon Joo Lee, Christopher W Boyce, Yi Wang, Robert Aslanian

Bioorg Med Chem Lett· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the development of histamine H3 antagonists.
Michael Berlin, Christopher W Boyce

Expert Opin Ther Pat· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Michael Berlin, Pauline C Ting, Wayne D Vaccaro, Robert Aslanian, Kevin D McCormick

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis